ArticleBioMed research international2026
SUVmax on
Article in BioMed research international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- SUVmax onBioMed research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study is aimed at evaluating the relationship between preoperative
methodsPatients diagnosed with OST and EWS between 2017 and 2023 were retrospectively analyzed. Data recorded included preoperative
resultsA total of 49 patients (33 OST and 16 EWS) were included, consisting of 22 females (44.9%) and 27 males (55.1%) with a median age of 12 years (range: 4-20). Median SUVmax1, SUVmax2, and SCR values were 6.8 (0-22.5), 2.5 (0-9.42), and 0.38 (0-1.44), respectively. The median tumor necrosis percentage was 20% (range: 0-100). Stratification according to SUVmax2 (< 2.5 vs. ≥ 2.5) revealed no significant difference in necrosis percentage (p = 0.234). No significant correlation was observed between SCR and necrosis percentage (p = 0.102). However, a significant inverse correlation was found between SUVmax2 and necrosis percentage in the overall cohort (p = 0.040, r = -0.295), which was more pronounced in OST patients (p = 0.014, r = -0.426).
conclusion
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.